Evidence map›Paper›PMID 27623803›Full record

ArticleCell and tissue research2017

A novel culture platform for fast proliferation of human annulus fibrosus cells.

Li Xiao, Mengmeng Ding, Osama Saadoon, Eric Vess, Andrew Fernandez, Ping Zhao, Li Jin, Xudong Li

Open access · greenAbstract read
In one paragraph

Article in Cell and tissue research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Intervertebral Disc-on-a-ChipAdvanced materials technologies · 2023
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Stem cell therapy in discogenic back pain.Journal of spine surgery (Hong Kong) · 2019
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Li Xiao *Department of Orthopaedic Surgery, University of Virginia, Cobb Hall, 135 Hospital Dr., Charlottesville, VA 22908.
Mengmeng Ding *Department of Orthopaedic Surgery, University of Virginia, Cobb Hall, 135 Hospital Dr., Charlottesville, VA 22908.
Osama SaadoonDepartment of Orthopaedic Surgery, University of Virginia, Cobb Hall, 135 Hospital Dr., Charlottesville, VA 22908.
Eric VessDepartment of Orthopaedic Surgery, University of Virginia, Cobb Hall, 135 Hospital Dr., Charlottesville, VA 22908.
Andrew FernandezDepartment of Orthopaedic Surgery, University of Virginia, Cobb Hall, 135 Hospital Dr., Charlottesville, VA 22908.
Ping ZhaoDepartment of Anesthesiology, China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, Liaoning, China 110004.
Li JinDepartment of Orthopaedic Surgery, University of Virginia, Cobb Hall, 135 Hospital Dr., Charlottesville, VA 22908.
Xudong LiDepartment of Orthopaedic Surgery, University of Virginia, Cobb Hall, 135 Hospital Dr., Charlottesville, VA 22908.
University of Virginia Hospital · USChina Medical University · CN

Funding

Systemic Application for Injury Site Specific Delivery via Neutrophils to Treat BR01AR064792 · NIAMS · UNIVERSITY OF VIRGINIA · PI LI, XUDONG J. · 2013 to 2018
$1.3M
Treatment of disc degeneration by nano-fullerenesR21AR057512 · NIAMS · UNIVERSITY OF VIRGINIA · PI LI, XUDONG J. · 2011 to 2012
$381k
NIAMS NIH HHS R01 AR064792NIAMS NIH HHS R21 AR057512
6 · The paper itself

Abstract

Tissue engineering provides a promising approach to treat degenerative disc disease, which usually requires a large quantity of seed cells. A simple and reliable in vitro culture system to expand seed cells in a timely fashion is necessary to implement the application clinically. Here, we sought to establish a cost-effective culture system for expanding human annulus fibrosus cells using extracellular matrix (ECM) proteins as culture substrates. Cells were cultured onto a plastic surface coated with various types of ECMs, including fibronectin, vitronectin, collagen type I, gelatin and cell-free matrix deposited by human nucleus pulposus cells. AF cell morphology, growth, adhesion and phenotype (anabolic and catabolic markers) were assessed by microscopy, real-time RT-PCR, western blotting, zymography, immunofluorescence staining and biochemical assays. Fibronectin, collagen and gelatin promoted cell proliferation and adhesion in a dose-dependent manner. Fibronectin elevated mRNA expression of proteoglycan and enhanced glycosaminoglycan production. Both collagen and gelatin increased protein expression of type II collagen. Consistent with increased cell adhesion, collagen and fibronectin promoted formation of focal adhesion complexes in the cell-matrix junction, suggesting enhanced binding of the actin network with both ECM substrates. On the other hand, fibronectin, collagen and gelatin decreased expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in media. Finally, a mixture of fibronectin (1.7 μg/mL) and collagen (1.3 μg/mL) was identified as the most promising in vitro culture substrate system in promoting proliferation and maintaining anabolic-catabolic balance. Our method provides a simple and cost-effective platform for tissue engineering applications in intervertebral disc research.

Indexed as

Annulus FibrosusCell AdhesionCell Culture TechniquesCell ProliferationCells, CulturedCollagenExtracellular MatrixFibronectinsFocal AdhesionsGelatinHumansMatrix Metalloproteinase 2Matrix Metalloproteinase 9PhenotypeRNA, MessengerSubstrate SpecificityCollagenFibronectinsGelatinMatrix Metalloproteinase 2Matrix Metalloproteinase 9RNA, MessengerVinculinCell proliferationExtracellular matrixIntervertebral disc degenerationIn vitro cultureTissue engineering

Identifiers

PMID27623803
PMCPMC5269443
OpenAlexW2519838117

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.